Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
================================================================================================================================

* Michael M. Boyiadzis
* Madhav V. Dhodapkar
* Renier J. Brentjens
* James N. Kochenderfer
* Sattva S. Neelapu
* Marcela V. Maus
* David L. Porter
* David G. Maloney
* Stephan A. Grupp
* Crystal L. Mackall
* Carl H. June
* Michael R. Bishop